EULAR recommendations for the management of rheumatoid …
WEBThis article provides evidence-based guidance on the use of synthetic and biological disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis (RA) patients. It covers the indications, goals, strategies, and monitoring of DMARDs therapy, as well as the role of biologic and targeted synthetic DMARDs.
ASAS-EULAR recommendations for the management of axial ...
WEBThis article provides evidence-based guidance for the management of axial spondyloarthritis (axSpA), a chronic inflammatory rheumatic disease. It covers diagnosis, treatment, monitoring, prognosis and comorbidities of axSpA, based on the latest literature and expert consensus.
Authors - Annals of the Rheumatic Diseases
WEBLearn about the editorial policies, licence types, preprints, article transfer service, ORCID, competing interests, data sharing and patient and public involvement of Annals of the Rheumatic Diseases. This journal is a Plan S compliant Transformative Journal and covers rheumatic diseases and related research.
EULAR recommendations for the management of ANCA …
WEBThis article provides evidence-based guidance for the diagnosis, treatment and follow-up of ANCA-associated vasculitis, a rare and severe inflammatory disease. It is a collaborative effort of experts from different countries and specialties, published in Annals of the Rheumatic Diseases.
Homepage | Annals of the Rheumatic Diseases
WEB2 days ago · ARD is an international peer-reviewed journal covering all aspects of rheumatology, including research, recommendations, and news. It publishes basic, clinical, and translational scientific research on musculoskeletal conditions, arthritic disease, and connective tissue disorders.
WEBMar 16, 2023 · This article provides updated guidance on the diagnosis and treatment of adult patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), including eosinophilic GPA (EGPA). It covers the use of biopsies, ANCA testing, glucocorticoids, rituximab, avacopan, mepolizumab and other therapies.
2022 American College of Rheumatology/EULAR classification …
WEBObjective To develop and validate updated classification criteria for giant cell arteritis (GCA). Methods Patients with vasculitis or comparator diseases were recruited into an international cohort. The study proceeded in six phases: (1) identification of candidate items, (2) prospective collection of candidate items present at the time of diagnosis, (3) expert panel review of cases, (4) data ...
The 2022 EULAR/ACR points to consider at the early stages of …
WEBResults The task force developed 6 overarching statements and 24 specific points to consider relevant to early recognition of HLH/MAS, diagnostic approaches, initial management and monitoring of HLH/MAS. Major themes included the simultaneous need for prompt syndrome recognition, systematic evaluation of underlying contributors, early intervention targeting both hyperinflammation and likely ...
2015 Gout classification criteria: an American College of …
WEBObjective Existing criteria for the classification of gout have suboptimal sensitivity and/or specificity, and were developed at a time when advanced imaging was not available. The current effort was undertaken to develop new classification criteria for gout. Methods An international group of investigators, supported by the American College of Rheumatology and the European League Against ...
WEBThis article reviews the clinical, serologic and epidemiologic aspects of systemic lupus erythematosus (SLE), a chronic autoimmune disease with variable severity and course. It also discusses the latest advances in disease classification, endotypes, treatment goals and strategies, and comorbidities.